Kestra Cash Conversion Cycle from 2010 to 2026
| KMTS Stock | 27.46 0.39 1.40% |
Cash Conversion Cycle | First Reported 2010-12-31 | Previous Quarter (148.29) | Current Value (155.71) | Quarterly Volatility 86.34547847 |
Check Kestra Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kestra Medical's main balance sheet or income statement drivers, such as Tax Provision of 81.4 K, Depreciation And Amortization of 5.6 M or Interest Expense of 4.6 M, as well as many indicators such as Price To Sales Ratio of 21.77, Dividend Yield of 0.0013 or PTB Ratio of 6.34. Kestra financial statements analysis is a perfect complement when working with Kestra Medical Valuation or Volatility modules.
Kestra | Cash Conversion Cycle | Build AI portfolio with Kestra Stock |
The evolution of Cash Conversion Cycle for Kestra Medical Technologies provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Kestra Medical compares to historical norms and industry peers.
Latest Kestra Medical's Cash Conversion Cycle Growth Pattern
Below is the plot of the Cash Conversion Cycle of Kestra Medical Technologies over the last few years. It is Kestra Medical's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kestra Medical's overall financial position and show how it may be relating to other accounts over time.
| Cash Conversion Cycle | 10 Years Trend |
|
Cash Conversion Cycle |
| Timeline |
Kestra Cash Conversion Cycle Regression Statistics
| Arithmetic Mean | (24.56) | |
| Geometric Mean | 33.15 | |
| Coefficient Of Variation | (351.54) | |
| Mean Deviation | 68.52 | |
| Median | 20.24 | |
| Standard Deviation | 86.35 | |
| Sample Variance | 7,456 | |
| Range | 268 | |
| R-Value | (0.69) | |
| Mean Square Error | 4,153 | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | (11.82) | |
| Total Sum of Squares | 119,289 |
Kestra Cash Conversion Cycle History
About Kestra Medical Financial Statements
Kestra Medical shareholders use historical fundamental indicators, such as Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although Kestra Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Kestra Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Kestra Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash Conversion Cycle | (148.29) | (155.71) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kestra Stock Analysis
When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.